News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
626,304 Results
Type
Article (48130)
Company Profile (201)
Press Release (577960)
Multimedia
Podcasts (156)
Webinars (22)
Section
Business (172968)
Career Advice (2543)
Deals (31950)
Drug Delivery (139)
Drug Development (76556)
Employer Resources (164)
FDA (16483)
Job Trends (13350)
News (306418)
Policy (32071)
Tag
Academia (2379)
Academic (1)
Accelerated approval (25)
Adcomms (35)
Allergies (123)
Alliances (43479)
ALS (158)
Alzheimer's disease (1694)
Antibody-drug conjugate (ADC) (282)
Approvals (16569)
Artificial intelligence (472)
Autoimmune disease (124)
Automation (26)
Bankruptcy (325)
Best Places to Work (9916)
BIOSECURE Act (23)
Biosimilars (187)
Biotechnology (101)
Bladder cancer (145)
Brain cancer (54)
Breast cancer (559)
Cancer (4265)
Cardiovascular disease (375)
Career advice (2149)
Career pathing (39)
CAR-T (251)
CDC (59)
Cell therapy (687)
Cervical cancer (33)
Clinical research (65008)
Collaboration (1376)
Company closure (4)
Compensation (1050)
Complete response letters (64)
COVID-19 (2756)
CRISPR (81)
C-suite (669)
Cystic fibrosis (134)
Data (5407)
Decentralized trials (2)
Denatured (41)
Depression (128)
Diabetes (445)
Diagnostics (5769)
Digital health (33)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (209)
Drug pricing (202)
Drug shortages (35)
Duchenne muscular dystrophy (218)
Earnings (72133)
Editorial (60)
Employer branding (20)
Employer resources (147)
Events (96030)
Executive appointments (911)
FDA (19210)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (17)
Funding (1211)
Gene editing (179)
Generative AI (42)
Gene therapy (553)
GLP-1 (1033)
Government (4247)
Grass and pollen (8)
Guidances (370)
Healthcare (15540)
HIV (50)
Huntington's disease (44)
IgA nephropathy (78)
Immunology and inflammation (266)
Immuno-oncology (36)
Indications (71)
Infectious disease (2997)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (97)
Intellectual property (206)
Interviews (468)
IPO (15202)
IRA (57)
Job creations (3771)
Job search strategy (1773)
Kidney cancer (16)
Labor market (76)
Layoffs (616)
Leadership (38)
Legal (7756)
Liver cancer (88)
Longevity (13)
Lung cancer (595)
Lymphoma (339)
Machine learning (36)
Management (55)
Manufacturing (672)
MASH (158)
Medical device (11739)
Medtech (11770)
Mergers & acquisitions (17696)
Metabolic disorders (1212)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (293)
Neuropsychiatric disorders (82)
Neuroscience (2799)
NextGen: Class of 2025 (5283)
Non-profit (3341)
Now hiring (34)
Obesity (599)
Opinion (292)
Ovarian cancer (136)
Pain (176)
Pancreatic cancer (184)
Parkinson's disease (260)
Partnered (27)
Patents (444)
Patient recruitment (366)
Peanut (52)
People (52330)
Pharmaceutical (80)
Pharmacy benefit managers (29)
Phase I (19548)
Phase II (28291)
Phase III (22442)
Pipeline (3679)
Policy (314)
Postmarket research (2553)
Preclinical (8135)
Press Release (48)
Prostate cancer (219)
Psychedelics (50)
Radiopharmaceuticals (248)
Rare diseases (764)
Real estate (5248)
Recruiting (68)
Regulatory (24068)
Reports (40)
Research institute (2233)
Resumes & cover letters (418)
Rett syndrome (23)
RNA editing (14)
RSV (71)
Schizophrenia (143)
Series A (208)
Series B (156)
Service/supplier (10)
Sickle cell disease (95)
Special edition (24)
Spinal muscular atrophy (157)
Sponsored (45)
Startups (3274)
State (2)
Stomach cancer (19)
Supply chain (101)
Tariffs (97)
The Weekly (113)
Vaccines (1050)
Venture capital (76)
Weight loss (427)
Women's health (61)
Worklife (21)
Date
Today (113)
Last 7 days (562)
Last 30 days (2249)
Last 365 days (29789)
2025 (28995)
2024 (33284)
2023 (37222)
2022 (47705)
2021 (51385)
2020 (48650)
2019 (39201)
2018 (29904)
2017 (30547)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (774)
Alabama (66)
Alaska (7)
Arizona (232)
Arkansas (11)
Asia (38435)
Australia (6276)
California (9872)
Canada (2645)
China (933)
Colorado (411)
Connecticut (456)
Delaware (301)
Europe (88161)
Florida (1488)
Georgia (301)
Hawaii (3)
Idaho (42)
Illinois (704)
India (56)
Indiana (430)
Iowa (20)
Japan (358)
Kansas (108)
Kentucky (34)
Louisiana (19)
Maine (72)
Maryland (1261)
Massachusetts (7227)
Michigan (254)
Minnesota (521)
Mississippi (5)
Missouri (107)
Montana (17)
Nebraska (23)
Nevada (105)
New Hampshire (62)
New Jersey (2723)
New Mexico (16)
New York (2589)
North Carolina (1337)
North Dakota (7)
Northern California (4770)
Ohio (261)
Oklahoma (16)
Oregon (34)
Pennsylvania (1948)
Puerto Rico (13)
Rhode Island (31)
South America (1140)
South Carolina (56)
South Dakota (1)
Southern California (3834)
Tennessee (149)
Texas (1466)
United States (35056)
Utah (254)
Virginia (237)
Washington D.C. (75)
Washington State (794)
West Virginia (4)
Wisconsin (94)
Wyoming (2)
626,304 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
February 26, 2025
·
3 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Press Releases
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
November 21, 2025
·
1 min read
Press Releases
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
November 19, 2025
·
2 min read
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
FDA
FDA’s Lost Leaders: Where Are They Now?
After a chaotic year that has seen the attrition of over half the FDA’s senior leadership, many of these individuals have landed new roles—at Eli Lilly, Pfizer, Iovance and more. The FDA’s loss, it seems, is largely the pharmaceutical industry’s gain.
October 20, 2025
·
8 min read
·
Heather McKenzie
Press Releases
Phlow Corp. CEO Outlines Path to Pharmaceutical Sovereignty in Testimony Before U.S. Senate
November 21, 2025
·
4 min read
1 of 62,631
Next